Vishal Kukreti
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments 108
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 29
- Oncology top 5%
- Cancer Treatment and Pharmacology 33
- Peptidase Inhibition and Analysis 18
- Viral-associated cancers and disorders 13
- Internal Medicine top 5%
-
- Lymphoma Diagnosis and Treatment 36
-
- Protein Degradation and Inhibitors 55
- Amyloidosis: Diagnosis, Treatment, Outcomes 20
- Co-authors
- Suzanne TrudelDonna ReeceChristine ChenJoseph MıkhaelEsther Masih‐KhanRodger E. TiedemannA. Keith StewartVíctor H. Jiménez‐Zepeda
- Cited by
- HematologyGeneticsOncology
- Journals
- Blood (88 papers)Journal of Clinical Oncology (20 papers)British Journal of Haematology (9 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Vishal Kukreti
185 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 102
- Hematology 1.4k
- Genetics 454
- Oncology 967
- Internal Medicine 101
- Pathology and Forensic Medicine 372
Countries citing papers authored by Vishal Kukreti
This map shows the geographic impact of Vishal Kukreti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vishal Kukreti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vishal Kukreti more than expected).
Fields of papers citing papers by Vishal Kukreti
This network shows the impact of papers produced by Vishal Kukreti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vishal Kukreti. The network helps show where Vishal Kukreti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vishal Kukreti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 3 | |
| 11 | 2020 | 4 | |
| 12 | 2018 | 46 | |
| 13 | 2017 | 101 | |
| 14 | 2017 | 5 | |
| 15 | 2017 | 1 | |
| 16 | 2016 | 12 | |
| 17 | 2014 | 35 | |
| 18 | 2013 | 3 | |
| 19 | 2011 | 5 | |
| 20 | 2008 | 72 |
About Vishal Kukreti
Vishal Kukreti is a scholar working on Hematology, Genetics and Oncology, having authored 207 papers that have together received 2.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (108 papers), Protein Degradation and Inhibitors (55 papers), Lymphoma Diagnosis and Treatment (36 papers), Cancer Treatment and Pharmacology (33 papers), Chronic Lymphocytic Leukemia Research (29 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (20 papers), Peptidase Inhibition and Analysis (18 papers) and Viral-associated cancers and disorders (13 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (454 citations) and Oncology (967 citations). Vishal Kukreti has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Suzanne Trudel, Donna Reece, Christine Chen, Joseph Mıkhael, Esther Masih‐Khan, Rodger E. Tiedemann, A. Keith Stewart, Víctor H. Jiménez‐Zepeda, Michael Crump and Christine I. Chen. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Bone Marrow Transplantation and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.